scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-8703(87)90666-1 |
P8608 | Fatcat ID | release_hge5pi6ozbeatmw3mwdbzpheha |
P698 | PubMed publication ID | 3591616 |
P50 | author | L. Adrienne Cupples | Q37638868 |
William B. Kannel | Q15439387 | ||
P2093 | author name string | Paffenbarger RS Jr | |
Kannel C | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | circulatory system | Q11068 |
P304 | page(s) | 1489-1494 | |
P577 | publication date | 1987-06-01 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | Heart rate and cardiovascular mortality: the Framingham Study | |
P478 | volume | 113 |
Q38086846 | 'Inappropriate' sinus tachycardia: does the 100 beats per min cut-off matter? |
Q56970799 | 2007 ESH‐ESC Guidelines for the management of arterial hypertension |
Q34936061 | 24-hour autonomic dysfunction and depressive behaviors in an animal model of social isolation: implications for the study of depression and cardiovascular disease |
Q91782679 | A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training |
Q41851953 | A comparison between heart rate and heart rate variability as indicators of cardiac health and fitness. |
Q47827264 | A genetic analysis of ambulatory cardiorespiratory coupling. |
Q38776088 | A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium |
Q81346285 | A new potential marker for abnormal cardiac physiology in depression |
Q24613583 | A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate |
Q57490321 | A similar 24‐h blood pressure control is obtained by zofenopril and candesartan in primary hypertensive patients |
Q37866294 | A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. |
Q88536384 | Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently |
Q58088698 | Admission heart rate as a predictor of mortality in patients with acute coronary syndromes |
Q47409523 | Adult height and the risk of cardiovascular disease among middle aged men and women in Japan |
Q39164200 | Advancements in pharmacotherapy for angina. |
Q50140868 | Age-dependent sympathetic neural responses to Β-1 selective beta-blockade in untreated hypertension-related tachycardia. |
Q42986821 | All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy |
Q28378188 | Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice |
Q41435381 | Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus |
Q85738904 | Analysis of factors related to vagally mediated reflex bradycardia during gastrectomy |
Q44630602 | Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs |
Q33533540 | Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction |
Q28291239 | Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial |
Q37672817 | Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study. |
Q54616735 | Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension. |
Q80810329 | Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study |
Q57488440 | Antihypertensive efficacy of zofenopril and hydrochlorothiazide combination on ambulatory blood pressure |
Q33995658 | Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality |
Q90282403 | Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients |
Q47439395 | Assessing resting heart rate in adolescents: determinants and correlates |
Q35684230 | Assessment of Association of Increased Heart Rates to Cardiovascular Events among Healthy Subjects in the United States: Analysis of a Primary Care Electronic Medical Records Database |
Q91705615 | Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study |
Q47892245 | Association Between Heart Rate and Subclinical Cerebrovascular Disease in the Elderly. |
Q37639142 | Association between Resting Heart Rate and Inflammatory Markers (White Blood Cell Count and High-Sensitivity C-Reactive Protein) in Healthy Korean People. |
Q28481738 | Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study |
Q36317496 | Association between resting heart rate and cardiovascular mortality: evidence from a meta-analysis of prospective studies |
Q37324823 | Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: a meta-analysis |
Q34795319 | Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis) |
Q51245292 | Association between resting heart rate, metabolic syndrome and cardiorespiratory fitness in Korean male adults. |
Q35011926 | Association between stressful life events and resting heart rate |
Q92366065 | Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study |
Q39667453 | Association of Heart Rate With Coronary Risk Factors and Increased White Blood Cell Counts in Healthy Japanese People |
Q39819895 | Association of an Index of Healthy Aging With Incident Cardiovascular Disease and Mortality in a Community-Based Sample of Older Adults |
Q34017121 | Association of exercise heart rate response and incidence of hypertension in men. |
Q89891134 | Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study |
Q35044359 | Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects |
Q47808175 | Associations of Insomnia Symptoms With Blood Pressure and Resting Heart Rate: The HUNT Study in Norway |
Q40295031 | Associations of resting heart rate with endothelium-dependent vasodilation and shear rate |
Q37306328 | Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease |
Q57309212 | Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death |
Q51294823 | Attenuated baroreflex sensitivity in normotensive prediabetes and diabetes in Indian adults. |
Q27004493 | Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity |
Q36438919 | Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives |
Q58413500 | Autonomic Stress Response Modes and Ambulatory Heart Rate Level and Variability |
Q36765722 | Autonomic cardiac control in depressed adolescents |
Q53624608 | Autonomic dysfunction assessed by EZSCAN and subclinical atherosclerosis. |
Q38170307 | Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice. |
Q35095473 | Biological mechanisms in the relationship between depression and heart disease |
Q33493202 | Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR) |
Q34045097 | Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. |
Q90218632 | Brain mechanisms of stress and depression in coronary artery disease |
Q48223493 | Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes |
Q36632992 | Cardiac autonomic control and the effects of age, race, and sex: the CARDIA study |
Q38202021 | Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. |
Q37461720 | Cardiovascular Safety Assessment in Early-Phase Clinical Studies: A Meta-Analytical Comparison of Exposure-Response Models. |
Q37562586 | Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials |
Q43963470 | Cardiovascular alterations and autonomic imbalance in an experimental model of depression |
Q34171759 | Cardiovascular effects of incretin therapy in diabetes care |
Q37619664 | Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment |
Q43008709 | Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power |
Q48329640 | Changes in Heart Rate Variability After Adenotonsillectomy in Children With Obstructive Sleep Apnea |
Q36736332 | Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice |
Q90387165 | Clinical Study Regarding Arrhythmogenic Risk Factors and Oxidative Stress Inductibility in Young People |
Q37974156 | Clinical outcomes in the management of congenital adrenal hyperplasia |
Q33610452 | Clinical presentation and management of stable coronary artery disease in Austria. |
Q86450989 | Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy |
Q36292056 | Cognition and Hemodynamics |
Q35581278 | Combined effects of depressive symptoms and resting heart rate on mortality: the Whitehall II prospective cohort study |
Q37976147 | Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. |
Q47443277 | Communication and Stress: Effects of Hope Evocation and Rumination Messages on Heart Rate, Anxiety, and Emotions After a Stressor |
Q42758573 | Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise |
Q42545413 | Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group |
Q50111064 | Comparison of cardiovascular risk profile between male employees of two automotives companies in France and Sweden. The Coeur Project Group |
Q35771801 | Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test |
Q34620940 | Comparison of the physiologic and prognostic implications of the heart rate versus the RR interval |
Q88711747 | Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? |
Q57316018 | Complex Segregation Analysis of Blood Pressure and Heart Rate Measured before and after a 20-Week Endurance Exercise Training Program: the Heritage Family Study |
Q55687041 | Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats. |
Q36817718 | Correlates of preclinical cardiovascular disease in Indigenous and Non-Indigenous Australians: a case control study |
Q38373654 | Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcom |
Q38697074 | Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure |
Q37230932 | DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years |
Q73932678 | Depression and coronary heart disease: observations and questions |
Q37599875 | Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications |
Q37143291 | Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms |
Q37673237 | Depressive behavior and coronary artery atherogenesis in adult female cynomolgus monkeys |
Q50195061 | Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1. |
Q34697669 | Diabetes, heart rate, and mortality |
Q30316590 | Direct inhibition, but indirect sensitization of pacemaker activity to sympathetic tone by the interaction of endotoxin with HCN-channels |
Q44773687 | Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? |
Q49887583 | Does resting heart rate measured by the physician reflect the patient's true resting heart rate? White-coat heart rate |
Q59913879 | Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation |
Q44623356 | Dyspnoea in chronic primary fibromyalgia |
Q34640857 | Early identification of risk factors for sudden cardiac death |
Q54945979 | Effect of Heart Rate-Oriented Therapy on Diastolic Functions in Patients with Heart Failure with Reduced Ejection Fraction. |
Q89868220 | Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials |
Q33717188 | Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy |
Q36522638 | Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects |
Q51706995 | Effect of cholinergic blockade on heart rate, blood pressure and plasma catecholamine responses to mental stress in normal subjects |
Q37677026 | Effect of depression and sertraline treatment on cardiac function in female nonhuman primates |
Q46574573 | Effect of diurnal temperature range on cardiovascular markers in the elderly in Seoul, Korea |
Q51623318 | Effect of heart rate on the risk of developing metabolic syndrome. |
Q33617828 | Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials |
Q37579594 | Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease |
Q51769228 | Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials. |
Q37250491 | Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice |
Q92741635 | Effects of baseline heart rate at sea level on cardiac responses to high-altitude exposure |
Q43446368 | Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials |
Q37143356 | Effects of long-term physical activity on cardiac structure and function: a twin study |
Q64885922 | Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia. |
Q43285131 | Effects of selective I f-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy |
Q44954440 | Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study |
Q57316179 | Electrocardiographic findings in a middle-aged African population in the Seychelles Islands |
Q44420051 | Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology |
Q35974310 | Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality |
Q36041575 | Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review |
Q36035810 | Elevated heart rate: a major risk factor for cardiovascular disease |
Q38689451 | Elevated resting heart rate is associated with the severity of coronary artery disease in non-treated patients who underwent coronary angiography: potential role of lipoprotein subfractions |
Q39678824 | Elevated resting heart rate is associated with white blood cell count in middle-aged and elderly individuals without apparent cardiovascular disease |
Q37827882 | Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises |
Q38116349 | Endothelium-dependent control of cerebrovascular functions through age: exercise for healthy cerebrovascular aging |
Q37281986 | Enhanced cardiac TBC1D10C expression lowers heart rate and enhances exercise capacity and survival. |
Q24814375 | Epidemiologic evidence of cardiovascular effects of particulate air pollution |
Q26830752 | Epidemiology of arrhythmias and conduction disorders in older adults |
Q46642724 | Ethnic differences in heart rate: can these be explained by conventional cardiovascular risk factors? |
Q72992813 | Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure |
Q37009578 | Evaluation of heart rate measurements in clinical studies: a prospective cohort study in patients with heart disease |
Q25257902 | Evidence for a gene influencing heart rate on chromosome 5p13-14 in a meta-analysis of genome-wide scans from the NHLBI Family Blood Pressure Program |
Q48783771 | Exenatide in type 2 diabetes |
Q33849850 | Experimental measurement of dynamic fluid shear stress on the aortic surface of the aortic valve leaflet |
Q38065321 | Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes |
Q36823856 | Factors determining case fatality in myocardial infarction "who dies in a heart attack"? |
Q35707442 | Fiber-based laser speckle imaging for the detection of pulsatile flow |
Q48020315 | Flexible Organic/Inorganic Hybrid Near-Infrared Photoplethysmogram Sensor for Cardiovascular Monitoring |
Q33882491 | Gender and incidence of dementia in the Framingham Heart Study from mid-adult life |
Q44003617 | Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults |
Q37216067 | Genesis and regulation of the heart automaticity. |
Q30313100 | Genetic loci associated with heart rate variability and their effects on cardiac disease risk |
Q24624928 | Genome-wide association analysis identifies multiple loci related to resting heart rate |
Q40161459 | Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts. |
Q57316003 | Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study |
Q36076531 | Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity |
Q48875887 | Guidelines' criteria for rate control in atrial fibrillation: are they useful? |
Q48231366 | Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy |
Q50777322 | Happiness and life satisfaction prospectively predict self-rated health, physical health, and the presence of limiting, long-term health conditions. |
Q64248551 | Heart Rate Is a Better Predictor of Cardiorespiratory Fitness Than Heart Rate Variability in Overweight/Obese Children: The ActiveBrains Project |
Q52020956 | Heart Rate Response to Psychological Stressors of Individuals Possessing Resting Bradycardia |
Q39493684 | Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. |
Q42643848 | Heart rate and cardiovascular disease: an alternative to Beta blockers |
Q37080140 | Heart rate and ischemic stroke: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
Q38669556 | Heart rate and its reduction in chronic heart failure and beyond |
Q43597755 | Heart rate and mortality in a Japanese general population: an 18-year follow-up study |
Q33985936 | Heart rate and risk of cancer death in healthy men |
Q34281167 | Heart rate as a cardiovascular risk factor: do women differ from men? |
Q28345818 | Heart rate as a predictor of mortality: the MATISS project |
Q34817084 | Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial |
Q33649639 | Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs |
Q51830152 | Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. |
Q42923271 | Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial |
Q37497745 | Heart rate as a treatable cardiovascular risk factor |
Q36999858 | Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms |
Q40557459 | Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study. |
Q51034680 | Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness. |
Q51566120 | Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort. |
Q41969828 | Heart rate differentiates urgency and emergency in hypertensive crisis |
Q85300166 | Heart rate in coronary artery disease: should we lower it? |
Q54414947 | Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. |
Q35859013 | Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. |
Q44799612 | Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction |
Q51734312 | Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker. |
Q37784463 | Heart rate reduction in cardiovascular disease and therapy |
Q38042855 | Heart rate reduction in heart failure: ivabradine or beta blockers? |
Q57303571 | Heart rate response during exercise test and cardiovascular mortality in middle-aged men |
Q34901289 | Heart rate variability and experimentally induced pain in healthy adults: a systematic review |
Q61659808 | Heart rate variability associated with particulate air pollution |
Q61851313 | Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study |
Q73798769 | Heart rate variability in workers exposed to carbon disulfide |
Q44602690 | Heart rate, ejection duration and subendocardial viability ratio in patients with rheumatoid arthritis as compared to controls |
Q33613139 | Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. |
Q92887784 | Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study |
Q53766023 | Hemodynamic stress and experimental aortoiliac atherosclerosis. |
Q37185043 | Heritability and linkage study on heart rates in a Mongolian population |
Q50267278 | High prevalence of prehypertension and hypertension in a working population in Hungary |
Q46158216 | Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population |
Q62667746 | How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure |
Q34560708 | How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data |
Q91559408 | Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease |
Q92801380 | Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin |
Q40502829 | Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality |
Q47114756 | If Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies. |
Q42861006 | Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure |
Q35881505 | Impact of Heart Rate on Myocardial Salvage in Timely Reperfused Patients with ST-Segment Elevation Myocardial Infarction: New Insights from Cardiovascular Magnetic Resonance. |
Q38686536 | Impact of Narrative Expressive Writing on Heart Rate, Heart Rate Variability, and Blood Pressure After Marital Separation |
Q64996381 | Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population. |
Q44584054 | Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity |
Q54328572 | Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study. |
Q47099826 | Impact of heart rate in atrial fibrillation versus sinus rhythm on mortality in octogenarian patients with acute coronary syndrome |
Q36383760 | Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy |
Q33586456 | Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). |
Q36835335 | In vivo MRI-based simulation of fatigue process: a possible trigger for human carotid atherosclerotic plaque rupture |
Q48743258 | Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency |
Q42722402 | Increased heart rate and atherosclerosis: potential implications of ivabradine therapy |
Q54102992 | Increased heart rate is associated with a prothrombotic state: The Framingham Heart Study. |
Q48183900 | Increased night heart rate is associated with worse large artery elasticity in chronic kidney disease patients. |
Q90581238 | Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational study |
Q35419662 | Increased resting heart rate with pollutants in a population based study |
Q28533685 | Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study |
Q34145473 | Increased total heart rate variability and enhanced cardiac vagal autonomic activity in healthy humans with sinus bradycardia |
Q47569154 | Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults |
Q58088640 | Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome |
Q50660284 | Integrating New Pharmacologic Agents into Heart Failure Care: Role of Heart Failure Practice Guidelines in Meeting This Challenge. |
Q38193910 | Interaction between heart rate and heart rate variability. |
Q34171833 | Interplay between heart rate and its variability: a prognostic game. |
Q38908301 | Is Heart Rate a Norepiphenomenon in Heart Failure? |
Q37992528 | Is heart rate a treatment target in heart failure? |
Q46332953 | Is there a better way to predict death using heart rate recovery? |
Q51738137 | Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis. |
Q34817043 | Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial |
Q49249173 | Ivabradine has a neutral effect on mortality in randomized controlled trials |
Q43068312 | Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice |
Q50895487 | Ivabradine in heart failure: NICE guidance. |
Q41216543 | Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration |
Q33937346 | Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series |
Q38052022 | Ivabradine: potential clinical applications in critically ill patients |
Q37831353 | Ivabradine: recent and potential applications in clinical practice |
Q33973963 | Ivabradine: the evidence of its therapeutic impact in angina |
Q45913258 | La fréquence cardiaque au repos : Un indicateur pronostique modifiable du risque et des issues cardiovasculaires ? |
Q37694331 | Late sinus and atrial tachycardia after pediatric heart transplantation might predict poor outcome |
Q34920627 | Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations |
Q38295604 | Long-Term Persistency of Abnormal Heart Rate Variability following Long NICU Stay and Surgery at Birth |
Q35021769 | Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study |
Q52222206 | Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. |
Q36995719 | Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models |
Q34441396 | Metabolic signatures of exercise in human plasma |
Q46225801 | Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists |
Q73739620 | Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokinetics |
Q37399776 | Mind and body: how the health of the body impacts on neuropsychiatry. |
Q34573112 | Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate |
Q39038606 | Murine Electrophysiological Models of Cardiac Arrhythmogenesis |
Q35544382 | Nemaline myopathy and heart failure: role of ivabradine; a case report |
Q33363027 | Nighttime heart rate and survival in depressed patients post acute myocardial infarction |
Q37250248 | Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients |
Q38529981 | Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome |
Q42759095 | Obesity: weighing the risk before prescribing |
Q31052717 | Office and 24-hour heart rate and target organ damage in hypertensive patients |
Q38233967 | Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors |
Q24187704 | Pharmacological interventions for clozapine-induced sinus tachycardia |
Q26471506 | Pharmacological interventions for clozapine-induced sinus tachycardia |
Q33611732 | Physical activity and ischaemic heart disease in middle-aged British men. |
Q60949807 | Physical activity may compensate for prolonged TV time regarding pulse rate-a cross-sectional study |
Q33772041 | Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes |
Q50538874 | Positive association between resting pulse and cancer incidence in current and former smokers. |
Q33545059 | Potential interests of heart rate lowering drugs |
Q74484776 | Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry) |
Q50213542 | Predicting Coronary Atherosclerotic Plaque Burden From Clinical Parameters: Bringing Old Knowledge in the Game |
Q36441990 | Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study |
Q91606722 | Predicting tachycardia as a surrogate for instability in the intensive care unit |
Q37374631 | Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study |
Q35684003 | Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction |
Q90095011 | Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation? |
Q36249527 | Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort |
Q37537663 | Protective role of resting heart rate on all-cause and cardiovascular disease mortality |
Q37510667 | Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements |
Q85648282 | Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey |
Q43662606 | Pulse pressure and heart rate: independent risk factors for cancer? |
Q75239566 | Pulse rate in childhood: reference limits |
Q79345669 | QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up |
Q46051385 | Rapid resting heart rate: a simple and powerful predictor of osteoporotic fractures and mortality in older women |
Q37810893 | Rate control with ivabradine: angina pectoris and beyond |
Q91869970 | Real-world heart rate norms in the Health eHeart study |
Q41653534 | Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality |
Q72561230 | Recalibration of normal sinus heart rate: clinical thinking and epidemiologic support |
Q46239241 | Reduced intrinsic heart rate is associated with reduced arrhythmic susceptibility in guinea-pig heart |
Q36355384 | Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms |
Q39083296 | Relation of Birth Weight to Heart Rate in Childhood, Adolescence, and Adulthood (from the Bogalusa Heart Study). |
Q30420730 | Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults study) |
Q42859076 | Relationship between resting electrocardiographic parameters and estimated 10-year risk for coronary heart disease in healthy adults in the USA. |
Q35599690 | Relationship of resting heart rate and physical activity with insulin sensitivity in a population-based survey |
Q34028226 | Relevance of heart rate as a risk factor in hypertension |
Q50019775 | Resting Heart Rate Trajectory Pattern Predicts Arterial Stiffness in a Community-Based Chinese Cohort |
Q37643822 | Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study |
Q45187664 | Resting Heart Rate as a Predictor of Body Weight Gain in the Early Stage of Hypertension |
Q34400715 | Resting heart rate and risk of cardiovascular diseases and all-cause death: the Kailuan study |
Q34345139 | Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs |
Q37092311 | Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study |
Q40614123 | Resting heart rate as a prognostic factor for mortality in patients with breast cancer |
Q43476890 | Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information? |
Q33682532 | Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). |
Q34633143 | Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study |
Q34089856 | Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia |
Q40955114 | Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population |
Q48745127 | Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study |
Q41759015 | Resting heart rate on the decline: the Tromsø Study 1986-2007. |
Q40867546 | Resting heart rate predicts incident myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: the Tromsø Study |
Q34774214 | Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? |
Q45751138 | Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease |
Q31127047 | Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record |
Q33568592 | Risk-benefit assessment of ivabradine in the treatment of chronic heart failure |
Q37986643 | Role of heart rate as a marker and mediator of poor outcome for patients with heart failure |
Q35771528 | Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies |
Q37111971 | Silencing of the Drosophila ortholog of SOX5 in heart leads to cardiac dysfunction as detected by optical coherence tomography |
Q28179461 | Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven? |
Q38934152 | Sinus tachycardia is associated with impaired exercise tolerance following heart transplantation. |
Q45984849 | Sleep-disordered breathing and daytime cardiac conduction abnormalities on 12-lead electrocardiogram in community-dwelling older men. |
Q48737333 | Sleep-related breathing disorder is an independent risk factor for systemic hypertension |
Q47327059 | Smartphone accelerometers for the detection of heart rate |
Q35185550 | Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. |
Q44105224 | Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring |
Q50531179 | Spot the red herring: breastfeeding, fruitpurée, and infant autonomic functioning-the generation R study. |
Q37035595 | Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models |
Q33711111 | Stress, depression, and coronary artery disease: modeling comorbidity in female primates |
Q34345278 | Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus |
Q37076040 | Submaximal Exercise Systolic Blood Pressure and Heart Rate at 20 Years of Follow-up: Correlates in the Framingham Heart Study |
Q34261790 | Sudden cardiac death and inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease |
Q35767296 | Sudden cardiac death in patients with diabetes |
Q36861254 | Sudden unexpected cardiac death as a function of time since the detection of electrocardiographic and clinical risk factors in apparently healthy men: the Manitoba Follow-Up Study, 1948 to 2004. |
Q38837789 | Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies. |
Q37200209 | Targeted ablation of cardiac sympathetic neurons reduces resting, reflex and exercise-induced sympathetic activation in conscious rats |
Q34980432 | Testing a workplace physical activity intervention: a cluster randomized controlled trial |
Q35803317 | Testing an association between baseline resting pulse rate averages and short-term changes in resting pulse rates: A pilot study. |
Q89522021 | The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys |
Q36228671 | The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey |
Q83193283 | The BEAUTIFUL study: is heart rate reduction a new therapeutic principle? |
Q46506630 | The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population |
Q36822268 | The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study |
Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
Q26741956 | The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients |
Q35227472 | The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health |
Q34332916 | The beta blockers: are they as protective in hypertension as in other cardiovascular conditions? |
Q35665387 | The broken heart: noninvasive measurement of cardiac autonomic tone |
Q35162676 | The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression |
Q93157484 | The cardiovascular phenotype of adult patients with phenylketonuria |
Q80159976 | The effect of 4-week chilli supplementation on metabolic and arterial function in humans |
Q37125667 | The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study |
Q88451108 | The effects of heart rate control in chronic heart failure with reduced ejection fraction |
Q38669129 | The efficacy of continuous positive airway pressure therapy in reducing cardiovascular events in obstructive sleep apnea: a systematic review |
Q35787800 | The factor-of-risk biomechanical approach predicts hip fracture in men and women: the Framingham Study |
Q37749825 | The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign? |
Q90299460 | The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction |
Q37739848 | The prognostic significance of heart rate for cardiovascular disease and hypertension |
Q68471205 | The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease |
Q89274861 | The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study |
Q34981000 | The role of cardiac autonomic function in hypertension and cardiovascular disease |
Q46621008 | The role of heart rate reduction in angina management and beyond |
Q58568726 | The therapeutic role of ivabradine in heart failure |
Q37118708 | Thyroid hormone levels within reference range are associated with heart rate, cardiac structure, and function in middle-aged men and women |
Q86747842 | Unaltered R-R interval variability and bradycardia in cyclists as compared with non-athletes |
Q92180650 | Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study |
Q64966612 | Using heart rate profiles during sleep as a biomarker of depression. |
Q34860874 | Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults |
Q28384493 | Very Long (> 48 hours) Shifts and Cardiovascular Strain in Firefighters: a Theoretical Framework |
Q37116321 | When heart goes "BOOM" to fast. Heart rate greater than 80 as mortality predictor in acute myocardial infarction |
Q33752515 | Where are we going with SSRIs? |
Q37615411 | Why are well-educated Muscovites more likely to survive? Understanding the biological pathways |
Q74013274 | Women with high exercise tolerance and the role of myocardial perfusion imaging |
Q73353152 | [Heart rate and isolated clinical tachycardia in hypertensive patients] |
Q83198023 | [Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement] |
Q33160305 | β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening |
Q37822723 | β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease |
Q48096584 | β1 -Adrenoceptor, but not β2 -adrenoceptor, subtype regulates heart rate in type 2 diabetic rats in vivo. |
Search more.